Skip to main content

Table 1 Summary of TCGA pan-cancer data

From: A pan-cancer study of selenoprotein genes as promising targets for cancer therapy

Primary disease type TCGAID Total N Primary tumor Normal tissue OS_censored OS_event
Adrenocortical cancer ACC 79 79 0 61 34
Bladder urothelial carcinoma BLCA 430 411 19 242 199
Breast invasive carcinoma BRCA 1217 1104 113 1035 209
Cervical and endocervical cancer CESC 309 306 3 227 77
Cholangiocarcinoma CHOL 45 36 9 38 30
Colon adenocarcinoma COAD 512 471 41 423 116
Diffuse large B-cell lymphoma DLBC 48 48 0 39 12
Esophageal carcinoma ESCA 173 162 11 140 109
Glioblastoma multiforme GBM 173 168 5 102 547
Head and neck squamous cell carcinoma HNSC 546 502 44 330 281
Kidney chromophobe KICH 89 65 24 160 22
Kidney clear cell carcinoma KIRC 607 535 72 638 341
Kidney papillary cell carcinoma KIRP 321 289 32 313 65
Acute myeloid leukemia LAML 151 151 0 168 458
Brain lower grade glioma LGG 529 529 0 392 141
Liver hepatocellular carcinoma LIHC 424 374 50 275 188
Lung adenocarcinoma LUAD 585 526 59 469 269
Lung squamous cell carcinoma LUSC 550 501 49 403 354
Mesothelioma MESO 86 86 0 12 74
Ovarian serous cystadenocarcinoma OV 379 379 0 296 435
Pancreatic adenocarcinoma PAAD 182 178 4 92 130
Pheochromocytoma and paraganglioma PCPG 186 183 3 181 8
Prostate adenocarcinoma PRAD 551 499 52 607 16
Rectum adenocarcinoma READ 177 167 10 144 34
Sarcoma SARC 265 263 2 175 112
Skin cutaneous melanoma SKCM 472 471 1 239 224
Stomach adenocarcinoma STAD 407 375 32 292 210
Testicular germ cell tumor TGCT 156 156 0 135 4
Thyroid carcinoma THCA 568 510 58 592 22
Thymoma THYM 121 119 2 126 12
Uterine corpus endometrioid carcinoma UCEC 583 548 35 490 100
Uterine carcinosarcoma UCS 56 56 0 21 40
Uveal melanoma UVM 80 80 0 57 23